Drugs.com - FDA MedWatch Alerts

Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle

Audience: Healthcare Provider, Pharmacy Foster City, Calif., September 20, 2024 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury (remdesivir) for Injection 100 mg/vial, to the consumer...

Feb 9, 2025 - 21:44
 0
Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle
Audience: Healthcare Provider, Pharmacy Foster City, Calif., September 20, 2024 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury (remdesivir) for Injection 100 mg/vial, to the consumer...
Read More

Tags:

Previous Article

FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

Next Article

Drug Safety Communication: FDA Adds Warning About Rare Occurrence of Serious Liv...

Related Posts

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)

FDA Investigating Serious Risk of Hematologic Malignanc...

Feb 9, 2025  0

FDA Warns Consumers to Not Purchase or Use Unapproved Inhalant Products Marketed for Alertness and Energy Boosting

FDA Warns Consumers to Not Purchase or Use Unapproved I...

Feb 9, 2025  0

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL (10mg/mL) Bags

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nation...

Feb 9, 2025  0